{
    "2021-11-15": [
        [
            {
                "time": "2022-10-15",
                "original_text": "Vaccines sent to some of the hardest to reach places with Zipline drone delivery",
                "features": {
                    "keywords": [
                        "vaccines",
                        "Zipline",
                        "drone delivery"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2022-10-15",
                "original_text": "Covid Cases Are Rising Again. Booster Rollout Could Expand as a Result.",
                "features": {
                    "keywords": [
                        "Covid",
                        "cases",
                        "rising",
                        "booster rollout"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2022-10-15",
                "original_text": "India's Dr. Reddy's open to making Pfizer COVID pill after Merck deal",
                "features": {
                    "keywords": [
                        "Dr. Reddy's",
                        "Pfizer",
                        "COVID pill",
                        "Merck deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2022-10-15",
                "original_text": "Ascendis (ASND) Gets Positive CHMP Opinion for GHD Drug Filing",
                "features": {
                    "keywords": [
                        "Ascendis",
                        "CHMP",
                        "GHD drug"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-10-15",
                "original_text": "J&J (JNJ) to Separate Consumer Unit Into New Company, Stock Up",
                "features": {
                    "keywords": [
                        "J&J",
                        "separate",
                        "consumer unit",
                        "stock up"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-10-15",
                "original_text": "4 Stocks Insiders Are Selling",
                "features": {
                    "keywords": [
                        "stocks",
                        "insiders",
                        "selling"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2022-10-15",
                "original_text": "Britain to extend COVID booster rollout to over-40s",
                "features": {
                    "keywords": [
                        "Britain",
                        "COVID booster",
                        "over-40s"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-10-15",
                "original_text": "Pfizer’s Big Gamble Is Paying Off. Its Stock Is a Good Long-Term Bet.",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "gamble",
                        "paying off",
                        "long-term bet"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-10-15",
                "original_text": "Will Johnson & Johnson’s Split Pay Off? History Says No.",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "split",
                        "history says no"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}